Living with ulcerative colitis while managing your weight can feel overwhelming. We're testing a combination approach that may help calm your UC symptoms while supporting meaningful weight loss—giving you the chance to feel better in two important ways.
This is a Phase 3 clinical trial that combines two medications to see if they work better together—one targeting your ulcerative colitis and one supporting weight management. Over about 13 months, you'll receive regular check-ins and careful monitoring to track how the treatment affects your symptoms and health. You'll be part of an important effort to discover treatments that address both conditions at once.
Contact us directly:
Phone: +1 657 230 7120
We're testing an investigational medication called SP-624 to help reduce depression symptoms. You'll receive either SP-624 or a placebo while being monitored closely by our caring team. This research could lead to better treatment options for people living with depression.
Learn MoreIf you completed our previous binge eating study, you're invited to continue your treatment journey with us. This next phase lets you keep accessing medication that may help reduce binge eating episodes, with close medical support every step of the way. You'll be part of important research that helps us understand how to best support people like you long-term.
Learn MoreAre you or a loved one experiencing agitation related to Alzheimer's disease? This research study is testing a new oral medication called BMS-986368 to help reduce agitation and improve quality of life. We're looking for participants ages 55-90 to join us in this important work.
Learn More